Pharmaron Beijing Balance Sheet Health
Financial Health criteria checks 5/6
Pharmaron Beijing has a total shareholder equity of CN¥13.4B and total debt of CN¥7.8B, which brings its debt-to-equity ratio to 58.3%. Its total assets and total liabilities are CN¥25.2B and CN¥11.9B respectively. Pharmaron Beijing's EBIT is CN¥1.6B making its interest coverage ratio 19.5. It has cash and short-term investments of CN¥5.4B.
Key information
58.3%
Debt to equity ratio
CN¥7.79b
Debt
| Interest coverage ratio | 19.5x |
| Cash | CN¥5.35b |
| Equity | CN¥13.36b |
| Total liabilities | CN¥11.89b |
| Total assets | CN¥25.24b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PHBB.F's short term assets (CN¥9.4B) exceed its short term liabilities (CN¥3.8B).
Long Term Liabilities: PHBB.F's short term assets (CN¥9.4B) exceed its long term liabilities (CN¥8.1B).
Debt to Equity History and Analysis
Debt Level: PHBB.F's net debt to equity ratio (18.2%) is considered satisfactory.
Reducing Debt: PHBB.F's debt to equity ratio has increased from 54.5% to 58.3% over the past 5 years.
Debt Coverage: PHBB.F's debt is well covered by operating cash flow (38.1%).
Interest Coverage: PHBB.F's interest payments on its debt are well covered by EBIT (19.5x coverage).